Melinta Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference

World News: . []

NEW HAVEN, Conn., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that Dan Wechsler, President and CEO of Melinta, will present at the Rodman & Renshaw 20 Annual Global Investment Conference in New York, NY. The presentation will take place on Weds., Sept. 5 at 12:05 p.m. Eastern Time.

A live and archived webcast of the presentation will be accessible from Melinta’s Investor Relations website at . The webcast can also be accessed from the following URL: .

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 13:00 GMT Wednesday 29th August 2018

Published: .

Search for other references to "melinta" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us